Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04495634 · ClinicalTrials.gov registry record · NA

Evaluation of a Carbon Nanotube Enabled Solid-State Head CT

A NA study of Head Trauma, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
17
Enrollment target
1
Study location

NCT04495634 is a NA study of Head Trauma that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 17 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04495634, a NA study of Head Trauma, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target
1
Study location

Study Summary

Purpose: The purpose of this study is to evaluate stationary head CT (s-HCT) as a diagnostic tool in patients with known head trauma. Participants: Participants will be 50 people who have had either a head trauma or a brain bleed and have undergone a head CT in the past 24 hours or who will undergo a CT scan of the head. Procedures (methods): This investigation will be a single arm, prospective clinical trial. Participants will have one single visit, which will include the s-HCT scan. No follow-up is required. All images will be de-identified before inclusion within a reader study. The investigators will perform a reader study with physician readers comparing the acquired imaging s-HCT images and conventional head CT.

Conditions Studied

Interventions

  • DEVICE Stationary Head CT (s-HCT)

Study Locations (1)

North Carolina

  • UNC Hospitals - Chapel Hill

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2022-10-12
Est. Completion 2023-09-13
Phase NA

What the Registry Record Tells You About NCT04495634

The ClinicalTrials.gov registry entry for NCT04495634 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Head Trauma appearing as the primary indexed condition, and to 1 intervention - of which Stationary Head CT (s-HCT) is the first listed.

NCT04495634 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT04495634 about?

NCT04495634 is a clinical study titled "Evaluation of a Carbon Nanotube Enabled Solid-State Head CT". Purpose: The purpose of this study is to evaluate stationary head CT (s-HCT) as a diagnostic tool in patients with known head trauma. Participants: Participants will be 50 people who have had either a head trauma or a brain bleed and have undergone a head CT in the past 24 hours or who will undergo...

What is the current status of trial NCT04495634?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2022-10-12. Estimated completion is 2023-09-13.

What conditions does trial NCT04495634 study?

This clinical trial studies the following conditions: Head Trauma.

What interventions are being tested in trial NCT04495634?

The interventions under investigation include: Stationary Head CT (s-HCT) (DEVICE).

Who is sponsoring clinical trial NCT04495634?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04495634 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head Trauma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.